1. Home
  2. YJ vs KPRX Comparison

YJ vs KPRX Comparison

Compare YJ & KPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yunji Inc. American Depository Shares

YJ

Yunji Inc. American Depository Shares

N/A

Current Price

$1.39

Market Cap

9.1M

ML Signal

N/A

Logo Kiora Pharmaceuticals Inc.

KPRX

Kiora Pharmaceuticals Inc.

HOLD

Current Price

$2.66

Market Cap

10.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YJ
KPRX
Founded
2015
1998
Country
China
United States
Employees
N/A
13
Industry
Other Specialty Stores
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1M
10.7M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
YJ
KPRX
Price
$1.39
$2.66
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
6.6K
25.8K
Earning Date
03-27-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$1.76
52 Week High
$2.67
$3.29

Technical Indicators

Market Signals
Indicator
YJ
KPRX
Relative Strength Index (RSI) 43.99 54.20
Support Level $1.42 $2.65
Resistance Level $1.74 $2.91
Average True Range (ATR) 0.12 0.13
MACD -0.01 -0.01
Stochastic Oscillator 38.10 50.00

Price Performance

Historical Comparison
YJ
KPRX

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in the PRC.

About KPRX Kiora Pharmaceuticals Inc.

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

Share on Social Networks: